Q2
CTVA — Q2 2026 Financial Report Analysis
Corteva's Q2 2026 sales dipped 1% to $6.38B and GAAP net income fell 12% on separation costs, litigation and currency losses, but Operating EBITDA rose to $2.26B as Seed margins widened; guidance was raised ahead of the October 1 Vylor seed spin-off.